Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow-to-Debt Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2023, meaning its operating cash flow of €2.10 Billion could theoretically repay 0% of its total liabilities (€38.23 Billion) in one year. Explore Guangzhou Baiyunshan Pharmaceutical Hold long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 13 annual periods. Also explore Guangzhou Baiyunshan Pharmaceutical Hold assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Year-by-year debt coverage analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For market capitalisation and broader financial context, see Guangzhou Baiyunshan Pharmaceutical Hold market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | €-232.46 Million | €44.43 Billion | ▼ -106.7% |
| 2024 | 0.08x | €3.44 Billion | €43.91 Billion | ▼ -19.9% |
| 2023 | 0.10x | €4.10 Billion | €41.91 Billion | ▼ -42.6% |
| 2022 | 0.17x | €7.00 Billion | €41.03 Billion | ▲ +4.6% |
| 2021 | 0.16x | €5.67 Billion | €34.79 Billion | ▲ +779.3% |
| 2020 | 0.02x | €585.19 Million | €31.55 Billion | ▼ -88.6% |
| 2019 | 0.16x | €5.02 Billion | €30.90 Billion | ▼ -11.7% |
| 2018 | 0.18x | €5.22 Billion | €28.34 Billion | ▼ -9.1% |
| 2017 | 0.20x | €1.83 Billion | €9.05 Billion | ▼ -34.4% |
| 2016 | 0.31x | €2.54 Billion | €8.24 Billion | ▲ +14.2% |
| 2015 | 0.27x | €1.94 Billion | €7.19 Billion | ▼ -1.9% |
| 2014 | 0.28x | €1.75 Billion | €6.34 Billion | ▲ +7.8% |
| 2013 | 0.26x | €1.34 Billion | €5.23 Billion | — |